148 related articles for article (PubMed ID: 38542194)
21. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
23. Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures.
Yang YC; Chien MH; Lai TC; Su CY; Jan YH; Hsiao M; Chen CL
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316576
[TBL] [Abstract][Full Text] [Related]
24. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
25. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
Clarke CN; Lee MS; Wei W; Manyam G; Jiang ZQ; Lu Y; Morris J; Broom B; Menter D; Vilar-Sanchez E; Raghav K; Eng C; Chang GJ; Simon I; Bernards R; Overman M; Mills GB; Maru D; Kopetz S
Ann Surg Oncol; 2017 Dec; 24(13):4051-4058. PubMed ID: 28936799
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
[TBL] [Abstract][Full Text] [Related]
27. Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer.
Sahu D; Lin CC; Goel A
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672877
[TBL] [Abstract][Full Text] [Related]
28. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.
Shi M; Beauchamp RD; Zhang B
PLoS One; 2012; 7(7):e41292. PubMed ID: 22844451
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.
Zhu J; Deane NG; Lewis KB; Padmanabhan C; Washington MK; Ciombor KK; Timmers C; Goldberg RM; Beauchamp RD; Chen X
Sci Rep; 2016 Sep; 6():33273. PubMed ID: 27623752
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
Chen Q; Tang P; Huang H; Qiu X
Front Immunol; 2022; 13():934124. PubMed ID: 35958575
[TBL] [Abstract][Full Text] [Related]
31. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
32. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
33. A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
Sho S; Court CM; Winograd P; Russell MM; Tomlinson JS
J Surg Oncol; 2017 Dec; 116(8):996-1004. PubMed ID: 28767131
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
[No Abstract] [Full Text] [Related]
35. Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing.
Kishigami F; Tanaka Y; Yamamoto Y; Ueno T; Kojima S; Sato K; Inoue S; Sugaya S; Ishihara S; Mano H; Kawazu M
Cancer Med; 2022 Sep; 11(18):3457-3470. PubMed ID: 35343095
[TBL] [Abstract][Full Text] [Related]
36. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
[TBL] [Abstract][Full Text] [Related]
37. Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification.
Novielli P; Romano D; Magarelli M; Bitonto PD; Diacono D; Chiatante A; Lopalco G; Sabella D; Venerito V; Filannino P; Bellotti R; De Angelis M; Iannone F; Tangaro S
Front Microbiol; 2024; 15():1348974. PubMed ID: 38426064
[TBL] [Abstract][Full Text] [Related]
38. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer.
Huang Y; Yin D; Wu L
Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436
[TBL] [Abstract][Full Text] [Related]
39. Exploring and validating the prognostic value of pathomics signatures and genomics in patients with cutaneous melanoma based on bioinformatics and deep learning.
Li X; Yu X; Tian D; Liu Y; Li D
Med Phys; 2023 Nov; 50(11):7049-7059. PubMed ID: 37722701
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
Sanz-Pamplona R; Berenguer A; Cordero D; Riccadonna S; Solé X; Crous-Bou M; Guinó E; Sanjuan X; Biondo S; Soriano A; Jurman G; Capella G; Furlanello C; Moreno V
PLoS One; 2012; 7(11):e48877. PubMed ID: 23145004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
